Doctor Giuseppe Galati

Doctor Giuseppe Galati

University of Milan, Milan (Italy)

Member of:

M.D, M.M.SC in Heart Failure, FHFA Senior Consultant Cardiologist, Specialist in Heart Failure and Cardiomyopathies at Unit of Cardiology, Cardiovascular and Thoracic Department, IRCCS - Multimedica (Cardiovascular Scientific Institute), Sesto San Giovanni, Milan, Italy. - HFA of ESC: Certification of Competence in Heart Failure. Heart Failure Certification Exam 2016 - CERTIFICATE IN HEART FAILURE MANAGEMENT after Postgraduate Course In Heart Failure London. Organized by the Zurich Heart House and endorsed by the HF British Society & by the British Cardiovascular Society (2019-21) - SECOND LEVEL MEDICAL MASTER ON COMPETENCE IN HEART FAILURE 2017 - Organized by the University of Florence and by the Italian Association of Hospital Cardiologists (ANMCO), Italy - EACVI of ESC: Level 1 certification in CMR - FELLOW of the HFA - MEMBER OF THE STUDY GROUP ON CARDIOMYOPATHIES 2020-2022 of HFA - ITALIAN FEDERATION OF CARDIOLOGY (IFC) Ambassador for HFA

Presentations

Hemodynamic arterial changes in heart failure. Shifting the paradigm from "heart" to "heart & vessels failure". The Copernican Revolution

Event: Heart Failure 2022

Topic: Pathophysiology

Session: Heart Failure ePosters - focus on Chronic Heart Failure 4

Access

Atrial fibrillation: the difference in thromboembolic events prognosis

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Cardiac arrest, rhythm and other

Access

Regular heart rhythm restoration after a period of asystole: modeling in experimental cardiology

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

Access

Hemodynamic arterial changes in heart failure. a proposed new paradigm of heart and vessels failure. The copernican revolution?

Event: ESC Congress 2021 - The Digital Experience

Topic: Haemodynamics of Heart Failure

Session: Chronic heart failure e-posters

Access

Hemodynamic arterial changes in heart failure. A proposed new paradigm of heart and vessels failure

Event: Heart Failure 2021

Topic: Haemodynamics of Heart Failure

Session: ePoster session

Access

Clinical spectrum and outcome of advanced heart failure in hypertrophic cardiomyopathy: from pathophysiology to contemporary unmet needs

Event: Heart Failure 2019

Topic: Clinical

Session: Myocardial Disease

Access

Clinicopathological profiles responsible for advanced heart failure, heart transplantation, left ventricular assist device implantation and death for heart failure in Hypertrophic cardiomyopathy

Event: ESC Congress 2018

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic cardiomyopathy

Access

Coronary microvascular pathology as the major determinant of severe fibrosis in end-stage hypertrophic cardiomyopathy (HCM)

Event: ESC Congress 2018

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic cardiomyopathy

Access

Clinical-pathological profiles responsible for advanced heart failure, heart transplantation, left ventricular assist device implantation and death for heart failure in Hypertrophic cardiomyopathy

Event: Heart Failure 2018

Topic: Hypertrophic Cardiomyopathy

Session: Myocardial Disease – Clinical

Access

Accuracy of LGE-CMR compared with histometric quantification of myocardial fibrosis in transplanted hearts of end-stage HCM

Event: ESC Congress 2017

Topic: Cardiomyopathies

Session: Cardiomyopathy

Access

Doctor Giuseppe Galati

Biography

Contributor content

Hemodynamic arterial changes in heart failure. Shifting the paradigm from "heart" to "heart & vessels failure". The Copernican Revolution

Atrial fibrillation: the difference in thromboembolic events prognosis

Regular heart rhythm restoration after a period of asystole: modeling in experimental cardiology

Hemodynamic arterial changes in heart failure. a proposed new paradigm of heart and vessels failure. The copernican revolution?

Hemodynamic arterial changes in heart failure. A proposed new paradigm of heart and vessels failure

Clinical spectrum and outcome of advanced heart failure in hypertrophic cardiomyopathy: from pathophysiology to contemporary unmet needs

Clinicopathological profiles responsible for advanced heart failure, heart transplantation, left ventricular assist device implantation and death for heart failure in Hypertrophic cardiomyopathy

Coronary microvascular pathology as the major determinant of severe fibrosis in end-stage hypertrophic cardiomyopathy (HCM)

Clinical-pathological profiles responsible for advanced heart failure, heart transplantation, left ventricular assist device implantation and death for heart failure in Hypertrophic cardiomyopathy

Accuracy of LGE-CMR compared with histometric quantification of myocardial fibrosis in transplanted hearts of end-stage HCM

ESC 365 is supported by